CCR2 antagonists: Completed Phase IIa enrollment

INCY completed enrollment of 48 RA patients, who are on methotrexate, in a 1-month, double-blind, placebo-controlled Phase IIa trial. The oral CCR2 antagonist also is in a similar Phase IIa trial in 1...